Clinical trials: Pharmacological Action

Healthy

A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects

• Completed
• Age: 18 to 65 years
• Phase 1

This study follows an open-label, single arm design with two periods with rosuvastatin, digoxin and ABBV-CLS-7262

Trial name

NCT05763459

Testing

ABBV-CLS-7262

Where

United States

Volunteers

12 people, healthy volunteers welcome

Sponsor

Calico Life Sciences LLC